Microneedle System for Transdermal Drug and Vaccine Delivery: Devices, Safety, and Prospects
Overview
Affiliations
Microneedle (MN) delivery system has been greatly developed to deliver drugs into the skin painlessly, noninvasively, and safety. In the past several decades, various types of MNs have been developed by the newer producing techniques. Briefly, as for the morphologically, MNs can be classified into solid, coated, dissolved, and hollow MN, based on the transdermal drug delivery methods of "poke and patch," "coat and poke," "poke and release," and "poke and flow," respectively. Microneedles also have other characteristics based on the materials and structures. In addition, various manufacturing techniques have been well-developed based on the materials. In this review, the materials, structures, morphologies, and fabricating methods of MNs are summarized. A separate part of the review is used to illustrate the application of MNs to deliver vaccine, insulin, lidocaine, aspirin, and other drugs. Finally, the review ends up with a perspective on the challenges in research and development of MNs, envisioning the future development of MNs as the next generation of drug delivery system.
Microneedles as a Promising Technology for Disease Monitoring and Drug Delivery: A Review.
Hulimane Shivaswamy R, Binulal P, Benoy A, Lakshmiramanan K, Bhaskar N, Pandya H ACS Mater Au. 2025; 5(1):115-140.
PMID: 39802146 PMC: 11718548. DOI: 10.1021/acsmaterialsau.4c00125.
Revolutionizing Eye Care: Exploring the Potential of Microneedle Drug Delivery.
Rojekar S, Parit S, Gholap A, Manchare A, Nangare S, Hatvate N Pharmaceutics. 2024; 16(11).
PMID: 39598522 PMC: 11597228. DOI: 10.3390/pharmaceutics16111398.
Nguyen L, Do X, Pham H, Duy-Thanh D, Than U, Nguyen T ACS Omega. 2024; 9(35):36926-36938.
PMID: 39246473 PMC: 11375714. DOI: 10.1021/acsomega.3c09351.
Limenh L, Worku N, Melese M, Esubalew D, Fenta E, Hailu M Diabetol Metab Syndr. 2024; 16(1):197.
PMID: 39152512 PMC: 11330025. DOI: 10.1186/s13098-024-01442-5.
Su T, Tang Z, Hu J, Zhu Y, Shen T Drug Deliv Transl Res. 2024; 14(11):3112-3127.
PMID: 38431532 DOI: 10.1007/s13346-024-01531-y.